John Kenneth Jenkins

Insider Reports History

Location
Norwood, MA
Signature
/s/ Meghan Houghton, attorney-in-fact for John Jenkins
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Kenneth Jenkins:

Company Role Class Num Shares Value Price $ Report Date Ownership
Corbus Pharmaceuticals Holdings, Inc. Director Common Stock, par value $0.0001 per share 2,816 $84,480 $30.00 30 May 2024 Direct
Corbus Pharmaceuticals Holdings, Inc. Director Common Stock, par value $0.0001 per share 4,833 $36,102 $7.47 30 May 2025 Direct
Corbus Pharmaceuticals Holdings, Inc. Director Stock options (right to buy) 16,000 30 May 2025 Direct
Provention Bio, Inc. Director Option to Purchase Common Stock 0 27 Apr 2023 Direct

Insider Reports Filed by John Kenneth Jenkins

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRBP Corbus Pharmaceuticals Holdings, Inc. 30 May 2025 3 -$20,465 4 Director 02 Jun 2025, 16:30
CRBP Corbus Pharmaceuticals Holdings, Inc. 30 May 2024 1 $0 4 Director 03 Jun 2024, 16:32
CRBP Corbus Pharmaceuticals Holdings, Inc. 16 May 2024 1 $0 4 Director 20 May 2024, 16:59
CRBP Corbus Pharmaceuticals Holdings, Inc. 18 May 2023 1 $0 4 Director 22 May 2023, 16:32
/report/000149315223013914-jenkins-john-kenneth-2023-04-27 Provention Bio, Inc. 27 Apr 2023 3 $0 4 Director 27 Apr 2023, 18:04
CRBP Corbus Pharmaceuticals Holdings, Inc. 18 May 2022 1 $0 4 Director 19 May 2022, 14:36
/report/000149315222014370-jenkins-john-kenneth-2022-05-17 Provention Bio, Inc. 17 May 2022 1 $0 4 Director 18 May 2022, 18:06
CRBP Corbus Pharmaceuticals Holdings, Inc. 17 Jun 2021 2 $0 4 Director 17 Jun 2021, 16:43
/report/000149315221011595-jenkins-john-kenneth-2021-05-12 Provention Bio, Inc. 12 May 2021 1 $0 4 Director 14 May 2021, 19:53